We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Following the Thursday confirmation of Robert F. Kennedy Jr. as head of Health and Human Services, doctors weigh in on the new secretary’s plans to make America healthy again.

Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...

Like many of President Donald Trump's appointees, Robert F. Kennedy, Jr., is promising to bring bold change and to “Make America Healthy Again.” ...

Robert F. Kennedy Jr, a vaccine critic who has pledged to tackle chronic disease, was named U.S. Health Secretary on Thursday ...

A New Hampshire economic official is warning that tariffs imposed by President Donald Trump are causing uncertainty in the marketplace.

It's time for us to pass this cost back to Big Pharma where it belongs,” Commissioner Cameron Davis said. “It's also time to not keep the burden on the shoulders of our taxpayers.” ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Corbus Pharmaceuticals (CRBP – Research ...

The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...